{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:23Z","timestamp":1786986923397,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clinbiochem.2026.111095","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:00:20Z","timestamp":1770397220000},"page":"111095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Application of thrombosis-related biomarkers in the diagnosis and thrombosis risk stratification of heparin-induced thrombocytopenia patients"],"prefix":"10.1016","volume":"142","author":[{"given":"Huiping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengju","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxue","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoukui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2026.111095_b0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally","year":"2020","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111095_b0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: a focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111095_b0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12959-023-00546-8","article-title":"How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation","volume":"21","author":"Barocas","year":"2023","journal-title":"Thromb. J."},{"key":"10.1016\/j.clinbiochem.2026.111095_b0020","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620971041","article-title":"Diagnostic and prognostic value of TAT, PIC, TM, and t-PAIC in malignant tumor patients with venous thrombosis","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.clinbiochem.2026.111095_b0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2018.11.010","article-title":"Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: a multi-center prospective observational study","volume":"173","author":"Mei","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clinbiochem.2026.111095_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119751","article-title":"Coagulation and fibrinolytic markers offer utility when distinguishing between benign and malignant gallbladder tumors: a cross-sectional study","volume":"560","author":"Huang","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111095_b0035","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70577","article-title":"Predictive model for early neurological deterioration in acute ischemic stroke utilizing novel thrombotic biomarkers","volume":"15","author":"Zhao","year":"2025","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111095_b0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12879-025-10574-6","article-title":"Elevated thrombosis-related biomarkers as predictors of disease severity and mortality in patients with severe fever with thrombocytopenia syndrome","volume":"25","author":"Lu","year":"2025","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111095_b0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"#cr-split#-10.1016\/j.clinbiochem.2026.111095_b0050.1","unstructured":"Editorial Board of Chinese Medical Journal. Chinese Expert Consensus on Heparin-Induced Thrombocytopenia (2017), Natl. Med. J. China. 98 (6) (2018) 408-417, http:\/\/dx.doi.org\/10.3760\/cma.j.issn.0376-2491.2018.06.003."},{"key":"#cr-split#-10.1016\/j.clinbiochem.2026.111095_b0050.2","unstructured":"Thrombosis Prevention and Treatment Professional Committee of the Cardiovascular Medicine Physician Branch, Chinese Medical Doctor Association; Editorial Board of Chinese Medical Journal. Chinese Expert Consensus on Heparin-Induced Thrombocytopenia (2017), Natl. Med. J. China. 98"},{"key":"#cr-split#-10.1016\/j.clinbiochem.2026.111095_b0050.3","unstructured":"(6) (2018) 408-417, http:\/\/dx.doi.org\/10.3760\/cma.j.issn.0376-2491.2018.06.003."},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111095_b0055","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1055\/s-0044-1786749","article-title":"Evaluating diagnostic algorithms for heparin-induced thrombocytopenia using two combined automated rapid immunoassays","volume":"50","author":"Bissola","year":"2024","journal-title":"Semin. Thromb. Hemost."},{"issue":"20","key":"10.1016\/j.clinbiochem.2026.111095_b0060","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111095_b0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/hematology.2024000566","article-title":"Practical guide to the diagnosis and management of heparin-induced thrombocytopenia","volume":"2024","author":"May","year":"2024","journal-title":"Hematology"},{"key":"10.1016\/j.clinbiochem.2026.111095_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101745","article-title":"A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: a prospective, multicenter, observational study","volume":"55","author":"Nilius","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.clinbiochem.2026.111095_b0075","doi-asserted-by":"crossref","unstructured":"M. Lundbech, A.E. Krag, T.D. Christensen, A.M. Hvas, Corrigendum to Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients, Thromb. Res. 216 (2022) 130\u2013132, https:\/\/doi.org\/10.1016\/j.thromres.2021.11.017.","DOI":"10.1016\/j.thromres.2021.11.017"},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111095_b0080","first-page":"1033","article-title":"Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome","volume":"55","author":"Hong","year":"2023","journal-title":"Beijing Da Xue Xue Bao"},{"issue":"21","key":"10.1016\/j.clinbiochem.2026.111095_b0085","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.clinbiochem.2026.111095_b0090","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111095_b0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1160\/TH03-07-0454","article-title":"Titre of anti-heparin\/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems","volume":"91","author":"Chilver-Stainer","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111095_b0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12185-024-03811-2","article-title":"Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis","volume":"120","author":"Mukherjee","year":"2024","journal-title":"Int. J. Hematol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111095_b0105","first-page":"1070","article-title":"The clinical significance of plasma thrombin-antithrombin complex levels in patients with septic cardiomyopathy","volume":"45","author":"Zhong","year":"2022","journal-title":"Chin. J. Lab. Med"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:09:19Z","timestamp":1773277759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":23,"alternative-id":["S0009912026000238"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111095","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of thrombosis-related biomarkers in the diagnosis and thrombosis risk stratification of heparin-induced thrombocytopenia patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111095"}}